Healthcare - NORD Pipera Hospital, part of the MedLife Group, marks a national premiere in interventional cardiology for the treatment of atrial fibrillation through ...

The cardiac ablation market growth is driven by the rising prevalence of cardiac arrhythmias, increasing awareness of minimally invasive treatment ...

Among patients with atrial fibrillation, those with a recent stroke are at significantly higher risk of recurrence than those without. Catheter ablation is expected to reduce the risk of ...

The field of atrial fibrillation is evolving rapidly. Although a medical rhythm control strategy has not proven to be beneficial for survival, new interventional therapies have improved the rate of ...

With CE mark approval, the pulsed field ablation procedure becomes available to treat patients in Europe with persistent atrial fibrillation.

Pulse Biosciences (NASDAQ:PLSE) used its fourth-quarter and full-year 2025 earnings call to outline progress across its ...

CFO Angie Wirick outlined the company’s early expectations for 2026 growth and discussed product adoption trends across its cardiac surgery and pain management franchises during an appearance at the ...

Tommaso Giacomel said he was struggling to breathe during his final ​​biathlon race at the 2026 Winter Olympics ...

Mary Strode, 74, joins Chest Heart & Stroke Scotland’s Voices of Experience Panel to share her atrial fibrillation and angina ...

Cappato et al. have reviewed the major causes of death in patients undergoing catheter ablation of atrial fibrillation. Many of these complications could be prevented by careful catheter manipulation, ...

This American Heart Month is a time to spread awareness about heart health and diagnoses that can be easy to miss. One of those diagnoses is Atrial Fibrillation.

Pulse Biosciences, Inc. , developer of the novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced first patient ...